Skip to content
10-K

Annual Report

QUANTRX BIOMEDICAL CORPORATION

0001493152-22-010071

← back to feed
Filed
Apr 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 31, 2022 78.7M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$49.48K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$74.92K
Cash And Equivalents FY 2021 · Dec 31, 2021 $5.95K
Cash And Equivalents FY 2021 · Dec 31, 2020 $55.43K
Stockholders Equity FY 2021 · Dec 31, 2021 −$2.64M
Stockholders Equity FY 2021 · Dec 31, 2020 −$2.38M
Stockholders Equity FY 2021 · Dec 31, 2019 −$2.13M
Total Liabilities FY 2021 · Dec 31, 2021 $2.65M
Total Liabilities FY 2021 · Dec 31, 2020 $2.44M
Current Assets FY 2021 · Dec 31, 2021 $5.95K
Current Assets FY 2021 · Dec 31, 2020 $55.43K
Total Assets FY 2021 · Dec 31, 2021 $5.95K
Total Assets FY 2021 · Dec 31, 2020 $55.43K
Sga Expense FY 2021 · Dec 31, 2021 $12.33K
Sga Expense FY 2021 · Dec 31, 2020 $12.73K
Net Income FY 2021 · Dec 31, 2021 −$260.04K
Net Income FY 2021 · Dec 31, 2020 −$252.73K
Operating Income FY 2021 · Dec 31, 2021 −$43.38K
Operating Income FY 2021 · Dec 31, 2020 −$60.62K